Key result
IV insulin safely cuts triglycerides by ~72% in a non-diabetic patient with acute pancreatitis.
Why the study?
Hypertriglyceridemic pancreatitis is a severe disease with higher complication rates and severity linked to triglyceride levels, requiring effective treatment strategies.
Does intravenous insulin infusion reduce triglyceride levels in non-diabetic patients with hypertriglyceridemic pancreatitis?
Case Report (n=1)
No
Does intravenous insulin infusion reduce triglyceride levels in non-diabetic patients with hypertriglyceridemic pancreatitis?
Intravenous insulin infusion safely and effectively rapidly reduces triglyceride levels in non-diabetic patients with hypertriglyceridemic pancreatitis.
Authors
No takes yet. Share an insight, caveat, or question.
HTGP case in hypertensive smoker highlights triglyceride-related risks; single report leaves open optimal acute management strategies.
Teneiji et al. (2025) conducted a case report in Hypertriglyceridemic Pancreatitis (n=1). Insulin infusion was evaluated on Reduction in serum triglyceride levels. Intravenous insulin infusion at 0.1 units/kg/hour safely reduced serum triglyceride levels from 1818 mg/dL to below 500 mg/dL over four days in a non-diabetic patient with acute pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: